NGL Fine Chem Ltd (NGLFINE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 700623,
    "name": "NGL Fine Chem",
    "stock_name": "NGL Fine Chem",
    "full_name": "NGL Fine Chem Ltd",
    "name_url": "stocks-analysis/ngl-fine-chem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,823.55",
    "chg": 73.55,
    "chgp": "4.2%",
    "dir": 1,
    "prev_price": "1,750.00",
    "mcapval": "1,093.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524774,
    "symbol": "NGLFINE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE887E01022",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "6.4 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/ngl-fine-chem-700623-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is NGL Fine Chem technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ngl-fine-chem-technically-bullish-or-bearish-3745353",
        "imagepath": "",
        "date": "2025-12-04 08:26:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 3 December 2025, NGL Fine Chem’s technical trend transitioned from mildly bullish to mildly bearish. This shift signals a cautious stance among traders and investors, reflecting growing uncertainty or potential downward momentum in the near term. Such a change often prompts market participants to reassess their positions, especially in a sector as sensitive as pharmaceuticals and biotechnology.</p>\n<p><strong>Key Technical Indicators Overview</strong></p>\n<p>Examining the primary technical indicators provides a nuanced picture of the stock’s momentum and potential direction:</p>\n<ul>\n<li><strong>MACD (Moving Average Convergence Divergence):</strong> The weekly MACD is mildly bearish, suggesting short-term momentum is weakening. However, the ..."
      },
      {
        "title": "NGL Fine Chem Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ngl-fine-chem-downgraded-to-sell-amid-weak-financials-and-bearish-technicals-3745488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NGLFineChem_mojoScore_3745488.png",
        "date": "2025-12-04 08:10:10",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation following recent changes across multiple analytical parameters. The company’s financial performance, valuation metrics, technical indicators, and quality measures collectively contribute to a revised perspective on its investment profile."
      },
      {
        "title": "NGL Fine Chem Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-faces-technical-setback-amid-price-momentum-shift-3745460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NGLFineChem_technicaldot_3745460.png",
        "date": "2025-12-04 08:08:48",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of indicator signals. Recent market data reveals a transition from mildly bullish to mildly bearish trends, underscoring a nuanced market assessment for the stock as it navigates fluctuating price dynamics and technical parameters."
      },
      {
        "title": "How has been the historical performance of NGL Fine Chem?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ngl-fine-chem-3744725",
        "imagepath": "",
        "date": "2025-12-03 22:49:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the seven-year period ending March 2025, NGL Fine Chem’s net sales exhibited a robust upward trend, rising from ₹153.17 crores in 2018-19 to ₹368.26 crores in 2024-25. This represents a compound growth trajectory, albeit with some volatility, such as a dip in 2020-21 followed by a recovery. Total operating income mirrored this pattern, reflecting the company’s core business expansion.</p>\n<p>Operating profit before depreciation and interest (PBDIT excluding other income) showed considerable variation, peaking at ₹79.74 crores in 2020-21 before declining to ₹33.87 crores in 2024-25. Including other income, operating profit followed a similar pattern, reaching a high of ₹87.76 crores in 2020-21 and settling at ₹42.50 crores in the latest fi..."
      },
      {
        "title": "NGL Fine Chem Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-technical-momentum-shifts-signal-mild-bullish-outlook-amid-mixed-indicators-3737486",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NGLFineChem_technicaldot_3737486.png",
        "date": "2025-12-01 08:02:55",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This development comes amid a complex backdrop of mixed signals from various technical indicators, reflecting a nuanced market assessment for the stock as it navigates current price levels and broader sector dynamics."
      },
      {
        "title": "NGL Fine Chem Surges to Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-hits-upper-circuit-amidst-unprecedented-buying-interest-3733046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NGLFineChem_only_buyers_3733046.png",
        "date": "2025-11-27 09:50:57",
        "description": "NGL Fine Chem has witnessed extraordinary buying momentum, hitting the upper circuit with a queue composed solely of buy orders. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, capturing the attention of investors and market watchers alike."
      },
      {
        "title": "NGL Fine Chem Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-hits-upper-circuit-amidst-unprecedented-buying-interest-3717454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NGLFineChem_only_buyers_3717454.png",
        "date": "2025-11-20 09:50:49",
        "description": "NGL Fine Chem Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the Pharmaceuticals & Biotechnology company."
      },
      {
        "title": "NGL Fine Chem: Analytical Review Highlights Financial and Technical Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ngl-fine-chem-downgraded-to-sell-amidst-flat-financials-and-weak-technicals-3717108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NGLFineChem_mojoScore_3717108.png",
        "date": "2025-11-20 08:09:25",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its evaluation reflecting shifts across quality, valuation, financial trends, and technical indicators. This comprehensive analysis explores the factors influencing the company's current market standing and performance metrics amid a challenging industry backdrop."
      },
      {
        "title": "How has been the historical performance of NGL Fine Chem?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ngl-fine-chem-3716178",
        "imagepath": "",
        "date": "2025-11-19 22:41:57",
        "description": "Answer:\nThe historical performance of NGL Fine Chem shows a fluctuating trend in key financial metrics over the years.\n\nBreakdown:\nNGL Fine Chem's net sales have generally increased from INR 151.69 crore in March 2020 to INR 368.26 crore in March 2025, with a notable dip in March 2022 to INR 317.50 crore. The total operating income followed a similar trajectory, reaching INR 368.26 crore in March 2025. However, total expenditure, excluding depreciation, rose significantly from INR 132.30 crore in March 2020 to INR 334.39 crore in March 2025. Operating profit (PBDIT) saw a peak of INR 87.76 crore in March 2021 but decreased to INR 42.50 crore by March 2025. Profit before tax mirrored this trend, peaking at INR 77.59 crore in March 2021 and dropping to INR 27.71 crore in March 2025. Profit after tax also fluctuated, reaching a high of INR 56.72 crore in March 2021 and declining to INR 21.12 crore in March 202..."
      }
    ],
    "total": 453,
    "sid": "700623",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/ngl-fine-chem-700623"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation",
      "datetime": "12-Jan-2026",
      "details": "NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve This is to inform you that the Fourth Board Meeting for the financial year 2025-26 of the Board of Directors of NGL Fine-Chem Limited will be held on Tuesday 3rd February 2026 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended on 31st December 2025. 2. Any other business with the permission of the chair.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "05-Jan-2026",
      "details": "Resignation of Company Secretary",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Jan-2026",
      "details": "Reg.74(5) submission",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "NGL Fine Chem Ltd has declared <strong>35%</strong> dividend, ex-date: 12 Aug 25",
          "dt": "2025-08-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is NGL Fine Chem technically bullish or bearish?

2025-12-04 08:26:19

Recent Technical Trend Shift As of 3 December 2025, NGL Fine Chem’s technical trend transitioned from mildly bullish to mildly bearish. This shift signals a cautious stance among traders and investors, reflecting growing uncertainty or potential downward momentum in the near term. Such a change often prompts market participants to reassess their positions, especially in a sector as sensitive as pharmaceuticals and biotechnology. Key Technical Indicators Overview Examining the primary technical indicators provides a nuanced picture of the stock’s momentum and potential direction: MACD (Moving Average Convergence Divergence): The weekly MACD is mildly bearish, suggesting short-term momentum is weakening. However, the ...

NGL Fine Chem Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals

2025-12-04 08:10:10

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation following recent changes across multiple analytical parameters. The company’s financial performance, valuation metrics, technical indicators, and quality measures collectively contribute to a revised perspective on its investment profile.

NGL Fine Chem Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-04 08:08:48

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of indicator signals. Recent market data reveals a transition from mildly bullish to mildly bearish trends, underscoring a nuanced market assessment for the stock as it navigates fluctuating price dynamics and technical parameters.

How has been the historical performance of NGL Fine Chem?

2025-12-03 22:49:01

Revenue and Profitability Trends Over the seven-year period ending March 2025, NGL Fine Chem’s net sales exhibited a robust upward trend, rising from ₹153.17 crores in 2018-19 to ₹368.26 crores in 2024-25. This represents a compound growth trajectory, albeit with some volatility, such as a dip in 2020-21 followed by a recovery. Total operating income mirrored this pattern, reflecting the company’s core business expansion. Operating profit before depreciation and interest (PBDIT excluding other income) showed considerable variation, peaking at ₹79.74 crores in 2020-21 before declining to ₹33.87 crores in 2024-25. Including other income, operating profit followed a similar pattern, reaching a high of ₹87.76 crores in 2020-21 and settling at ₹42.50 crores in the latest fi...

NGL Fine Chem Technical Momentum Shifts Amid Mixed Market Signals

2025-12-01 08:02:55

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This development comes amid a complex backdrop of mixed signals from various technical indicators, reflecting a nuanced market assessment for the stock as it navigates current price levels and broader sector dynamics.

NGL Fine Chem Surges to Upper Circuit Amidst Unprecedented Buying Interest

2025-11-27 09:50:57

NGL Fine Chem has witnessed extraordinary buying momentum, hitting the upper circuit with a queue composed solely of buy orders. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, capturing the attention of investors and market watchers alike.

NGL Fine Chem Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-11-20 09:50:49

NGL Fine Chem Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the Pharmaceuticals & Biotechnology company.

NGL Fine Chem: Analytical Review Highlights Financial and Technical Shifts Amid Market Challenges

2025-11-20 08:09:25

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its evaluation reflecting shifts across quality, valuation, financial trends, and technical indicators. This comprehensive analysis explores the factors influencing the company's current market standing and performance metrics amid a challenging industry backdrop.

How has been the historical performance of NGL Fine Chem?

2025-11-19 22:41:57

Answer: The historical performance of NGL Fine Chem shows a fluctuating trend in key financial metrics over the years. Breakdown: NGL Fine Chem's net sales have generally increased from INR 151.69 crore in March 2020 to INR 368.26 crore in March 2025, with a notable dip in March 2022 to INR 317.50 crore. The total operating income followed a similar trajectory, reaching INR 368.26 crore in March 2025. However, total expenditure, excluding depreciation, rose significantly from INR 132.30 crore in March 2020 to INR 334.39 crore in March 2025. Operating profit (PBDIT) saw a peak of INR 87.76 crore in March 2021 but decreased to INR 42.50 crore by March 2025. Profit before tax mirrored this trend, peaking at INR 77.59 crore in March 2021 and dropping to INR 27.71 crore in March 2025. Profit after tax also fluctuated, reaching a high of INR 56.72 crore in March 2021 and declining to INR 21.12 crore in March 202...

View All News